175 related articles for article (PubMed ID: 21881977)
1. Endothelin-induced changes in blood flow in STZ-diabetic and non-diabetic rats: relation to nitric oxide synthase and cyclooxygenase inhibition.
Granstam SO; Granstam E
J Physiol Sci; 2011 Nov; 61(6):497-505. PubMed ID: 21881977
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Paramar AN; Balaraman R
Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
[TBL] [Abstract][Full Text] [Related]
3. Contribution of endothelin receptors and cyclooxygenase-derivatives to the altered response of the rabbit renal artery to endothelin-1 in diabetes.
Marrachelli VG; Miranda FJ; Alabadí JA; Lloréns S; Alborch E
Eur J Pharmacol; 2006 Mar; 534(1-3):178-86. PubMed ID: 16612843
[TBL] [Abstract][Full Text] [Related]
4. Exercise training enhances flow-induced vasodilation in skeletal muscle resistance arteries of aged rats: role of PGI2 and nitric oxide.
Spier SA; Delp MD; Stallone JN; Dominguez JM; Muller-Delp JM
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3119-27. PubMed ID: 17337602
[TBL] [Abstract][Full Text] [Related]
5. In vivo regulation of endothelium-dependent vasodilation in the rat renal circulation and the effect of streptozotocin-induced diabetes.
Edgley AJ; Tare M; Evans RG; Skordilis C; Parkington HC
Am J Physiol Regul Integr Comp Physiol; 2008 Sep; 295(3):R829-39. PubMed ID: 18635451
[TBL] [Abstract][Full Text] [Related]
6. Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and alpha1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes.
Bender SB; Klabunde RE
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2281-8. PubMed ID: 17660396
[TBL] [Abstract][Full Text] [Related]
7. Involvement of nitric oxide in the regulation of regional hemodynamics in streptozotocin-diabetic rats.
Granstam E; Granstam SO
Physiol Res; 2003; 52(2):159-69. PubMed ID: 12678658
[TBL] [Abstract][Full Text] [Related]
8. Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats.
Hercule HC; Oyekan AO
Am J Physiol Regul Integr Comp Physiol; 2000 Dec; 279(6):R2132-41. PubMed ID: 11080078
[TBL] [Abstract][Full Text] [Related]
9. Possible modulation by endothelin-1, nitric oxide, prostaglandin I2 and thromboxane A2 of vasoconstriction induced by an alpha-agonist in mesenteric arterial bed from diabetic rats.
Makino A; Kamata K
Diabetologia; 1998 Dec; 41(12):1410-8. PubMed ID: 9867207
[TBL] [Abstract][Full Text] [Related]
10. Altered microvascular reactivity to endothelin-1, endothelin-3 and NG-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus.
Lawrence E; Brain SD
Br J Pharmacol; 1992 Aug; 106(4):1035-40. PubMed ID: 1393277
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase inhibition reduces blood pressure elevation and vascular reactivity dysfunction caused by inhibition of nitric oxide synthase in rats.
da Cunha V; Rossoni LV; Oliveira PA; Poton S; Pretti SC; Vassallo DV; Stefanon I
Clin Exp Hypertens; 2000 Feb; 22(2):203-15. PubMed ID: 10744360
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro action of endothelin-1 on goat cerebrovascular bed.
Fernández N; Monge L; García JL; García-Villalón AL; Gómez B; Diéguez G
Eur J Pharmacol; 1998 May; 348(2-3):199-211. PubMed ID: 9652335
[TBL] [Abstract][Full Text] [Related]
13. NO- and non-NO-, non-prostanoid-dependent vasodilatation in rat sciatic nerve during maturation and developing experimental diabetic neuropathy.
Thomsen K; Rubin I; Lauritzen M
J Physiol; 2002 Sep; 543(Pt 3):977-93. PubMed ID: 12231652
[TBL] [Abstract][Full Text] [Related]
14. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H
Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531
[TBL] [Abstract][Full Text] [Related]
15. Contributions of endothelium-derived relaxing factors to control of hindlimb blood flow in the mouse in vivo.
Fitzgerald SM; Bashari H; Cox JA; Parkington HC; Evans RG
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1072-82. PubMed ID: 17468338
[TBL] [Abstract][Full Text] [Related]
16. Regulation of uveal and retinal blood flow in STZ-diabetic and non-diabetic rats; involvement of nitric oxide.
Granstam E; Granstam SO
Curr Eye Res; 1999 Oct; 19(4):330-7. PubMed ID: 10520229
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 products compensate for inhibition of nitric oxide regulation of renal perfusion.
Beierwaltes WH
Am J Physiol Renal Physiol; 2002 Jul; 283(1):F68-72. PubMed ID: 12060588
[TBL] [Abstract][Full Text] [Related]
18. Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat.
Chen YJ; Li J; Quilley J
Eur J Pharmacol; 2006 Jul; 541(1-2):80-6. PubMed ID: 16753143
[TBL] [Abstract][Full Text] [Related]
19. Regional hemodynamics after chronic nitric oxide inhibition in spontaneously hypertensive rats.
Varagic J; Jerkic M; Jovovic D; Nastic-Miric D; Adanja-Grujic G; Markovic-Lipkovski J; Lackovic V; Radujkovic-Kuburovic G; Kentera D
Am J Med Sci; 2000 Sep; 320(3):171-6. PubMed ID: 11014370
[TBL] [Abstract][Full Text] [Related]
20. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R
Life Sci; 2006 Apr; 78(22):2615-24. PubMed ID: 16318863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
